Market Cap : 1.7 B | Enterprise Value : 1.54 B | PE Ratio : | PB Ratio : 18.66 |
---|
NAS:IMGN has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
NAS:IMGN has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Immunogen's Other Current Receivables for the quarter that ended in Sep. 2020 was $18.2 Mil.
Immunogen's quarterly Other Current Receivables declined from Mar. 2020 ($15.72 Mil) to Jun. 2020 ($15.13 Mil) but then increased from Jun. 2020 ($15.13 Mil) to Sep. 2020 ($18.19 Mil).
Immunogen's annual Other Current Receivables increased from Dec. 2017 ($2.58 Mil) to Dec. 2018 ($10.37 Mil) and increased from Dec. 2018 ($10.37 Mil) to Dec. 2019 ($19.75 Mil).
* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.
GuruFocus uses a standardized financial statement format for all companies. GuruFocus lists Accounts Receivable, Notes Receivable , Loans Receivable and Other Current Receivables under the "Total Receivables" section.
No Headline